Grifols one of 500 best companies in the world to work for, according to Forbes Magazine


  • Grifols is one of only three Spanish companies included in the list of "500 World's Best Employers" compiled by Forbes and Statista
  • The company's presence in the ranking confirms its excellent reputation as a global employer and its ongoing commitment to attracting and developing talent
  • Grifols currently employs almost 18,000 people across the globe, an increase of 29% since 2014

Barcelona, November 15, 2017: Grifolsi, leader in the production of plasma-derived medicines and in diagnostic and hospital solutions to improve people's health, has been recognized by Forbes Magazine and Statista as one of the 500 best companies in the world to work for. Grifols has been ranked 415th in the list of "500 World's Best Employers", and is one of only three Spanish companies included.

To select the best companies, Statista analyzed more than 360,000 proposals and recommendations related to different aspects of human resource management, submitted by employees in 61 different countries via large-scale global and regional surveys. Grifols obtained 75.51 points out of a maximum of 100, confirming its solid position and its reputation, both internally and externally, as a global employer.

One of the key goals of Grifols' Human Resources activities is to ensure the professional development of a workforce of more than 18,000 employees in 30 countries, which it recognizes as essential to the challenge of delivering global growth and promoting competitiveness. The company established the Grifols Academy in 2009 to provide training opportunities for its employees. To date, the Academy has delivered a wide range of courses to more than 10,000 members of staff, providing more than 320,000 hours of training.

Grifols also advocates an equal opportunities policy with respect to recruitment, training, remuneration, promotion and professional development. This commitment helps the company to attract and retain teams of professionals who research, develop, manufacture and sell products that improve the health and well-being of patients across the globe.

The company's workforce has grown by 29% over the last three yearsii:

  • 2014 – 13,980
  • 2015 – 14,730  (+ 5.4%)
  • 2016 – 15,109  (+ 2.6%)
  • 2017 – 18,071  (+19.6%)

iGrifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS)
iiFigures for December of each year, except 2017 (October)